These findings demonstrate that co-modulation of 5-HT4 receptors and PDE7 enzymes enhances memory performance through a synergistic mechanism, likely though convergent activation of the cAMP/PKA/CREB signaling cascade. This study provides compelling preclinical proof of concept supporting the development of multi-target pharmacological strategies for cognitive decline.
Ridant et al. (Wed,) studied this question.